22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/21/22 | 8-K | Current report filing |
|
   |
3 |
| 01/13/22 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 12/30/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/23/21 | 8-K | Current report filing |
|
|
4 |
| 12/22/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
3 | |
| 12/16/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/19/21 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 11/19/21 | 8-K | Current report filing |
|
|
9 |
| 11/04/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
42 |
| 11/04/21 | 8-K | Current report filing |
|
|
32 |
